A Survey of Sexual Function in Schizophrenic Patients
NCT01835522 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-08-04
Summary
The goal of this study is to survey patients with a diagnosis of schizophrenia to determine if there is a relationship between self-reported sexual function and treatment with antipsychotic medication.
Hypotheses: 1. Patients on typical antipsychotics will rate their sexual function as lower than those on atypical agents. 2. Patients on multiple antipsychotics will rate their sexual function as lower than those on a single agent.
Conditions
- Sexual Dysfunction
Sponsors & Collaborators
-
Sexual Medicine Society of North America
collaborator UNKNOWN -
Beth Israel Medical Center
lead OTHER
Principal Investigators
-
Dennis Lin, MD · Beth Israel Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
Countries
- United States
Study Locations
More Related Trials
-
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
NCT00937755 ·Status: COMPLETED
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
NCT00063297 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia
NCT00893256 ·Status: COMPLETED ·Phase: PHASE4
-
A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition
NCT00525304 ·Status: COMPLETED ·Phase: NA
-
Music Therapy for People With Schizophrenia and Relates Psychosis.
NCT04777266 ·Status: COMPLETED ·Phase: NA
-
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529 ·Status: COMPLETED ·Phase: PHASE4
-
The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With Schizophrenia
NCT01139099 ·Status: COMPLETED ·Phase: NA
-
Assessment of Schizophrenia Patients' Clinical Study Experiences
NCT05948111 ·Status: NOT_YET_RECRUITING
-
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
NCT00455663 ·Status: COMPLETED ·Phase: NA
-
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 ·Status: COMPLETED
-
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659 ·Status: COMPLETED
-
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
NCT02775864 ·Status: COMPLETED
-
Schizophrenia and the Gut Microbiome
NCT02921243 ·Status: COMPLETED
-
Self-Management Therapy for Youth With Schizophrenia
NCT00000387 ·Status: COMPLETED ·Phase: PHASE3
-
Peer-led Psycho-education for Schizophrenia
NCT03246932 ·Status: COMPLETED ·Phase: NA
-
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
NCT00759421 ·Status: COMPLETED ·Phase: PHASE3
-
Generalization of Training in Schizophrenia
NCT00108199 ·Status: COMPLETED ·Phase: NA
-
Cognition, Functioning and Quality of Life
NCT00182442 ·Status: COMPLETED ·Phase: PHASE4
-
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
NCT00495352 ·Status: COMPLETED ·Phase: PHASE4
-
Biological Implications of the Overlapping Phenomenon Between Childhood Schizophrenia and Autism Spectrum Disorders-Heterogeneity Approach Rather Than Diagnostic Boundary
NCT06063525 ·Status: UNKNOWN
-
The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
NCT04076371 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
NCT00097942 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
NCT01394471 ·Status: COMPLETED ·Phase: PHASE1